Skip to main content
. 2016 Mar 23;7(22):31993–32005. doi: 10.18632/oncotarget.8289

Table 3. SOX2 expressions and clinicopathological characteristics of GC.

Clinical and pathological data Case number SOX2 Positive rate (%) P
Negative Positive
Age (year)
 < 60 28 19 9 32.14 0.397
 ≥ 60 32 25 7 21.88
Sex
 male 29 23 6 20.69 0.387
 female 31 21 10 32.26
Tumor location
 Near the pylorus 33 25 8 24.24 0.771
 Near the cardia 27 19 8 29.63
Differentiation degree
 Moderately to well differentiated 36 22 14 38.89 0.015
 Poorly to non-differentiated 24 22 2 8.33
LNM
 without metastasis 33 18 15 45.45 2.745E-4
 with metastasis 27 26 1 3.70
TNM staging
 I/II staging 30 16 14 46.67 4.596E-4
 III/IV staging 30 28 2 6.67

GC, gastric cancer.